| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... Oncotarget 7 (37), 60535, 2016 | 83 | 2016 |
| Epigenome engineering in cancer: fairytale or a realistic path to the clinic? F Falahi, A Sgro, P Blancafort Frontiers in oncology 5, 22, 2015 | 75 | 2015 |
| Epigenome engineering: new technologies for precision medicine A Sgro, P Blancafort Nucleic acids research 48 (22), 12453-12482, 2020 | 52 | 2020 |
| The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer E Golden, R Rashwan, EA Woodward, A Sgro, E Wang, A Sorolla, ... Nature Communications 12 (1), 1920, 2021 | 28 | 2021 |
| Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine X Dai, P Blancafort, P Wang, A Sgro, EW Thompson, K Ostrikov Advanced science 7 (12), 1902552, 2020 | 14 | 2020 |
| Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma A Sgro, J Cursons, C Waryah, EA Woodward, M Foroutan, R Lyu, ... Clinical Epigenetics 15 (1), 73, 2023 | 9 | 2023 |
| SP94-targeted nanoparticles enhance the efficacy of sorafenib and improve liver cancer cell discrimination M Chopra, A Sgro, M Norret, P Blancafort, KS Iyer, CW Evans ACS Applied Bio Materials 4 (1), 1023-1029, 2020 | 7 | 2020 |
| Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system. Oncotarget 7: 60535–60554 B Garcia-Bloj, C Moses, A Sgro, J Plani-Lam, M Arooj, C Duffy, ... | 7 | 2016 |
| A Peptide-Functionalised Dendronised Polymer for Selective Transfection in Human Liver Cancer Cells M Chopra, A Sgro, M Norret, P Blancafort, S Iyer, CW Evans New Journal of Chemistry, 2021 | 1 | 2021 |
| Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer A Redfern, R Rashwan, A Sorolla, M Ratajska, I Kardas, A Kuzniacka, ... Cancer Research 76, 2016 | | 2016 |
| Abstract P2-06-01: Characterisation of C11orf67, an oncogenic driver in a new subtype of aggressive endocrine receptor positive breast cancer A Redfern, R Rashwan, A Sorolla, M Ratajska, I Kardas, A Kuzniacka, ... Cancer Research 76 (4_Supplement), P2-06-01-P2-06-01, 2016 | | 2016 |
| CRISPR-like genome editing tool-mediated down regulation of CAMK2D: A potential role for epigenetics intervention in the treatment of cardiac hypertrophy J Constantine, A Sgro, C Moses, P Blancafort, L Hool Heart, Lung and Circulation 24, S177, 2015 | | 2015 |
